This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2008 Nov;63(11):1026-7; author reply 1027.

Biases in the observational study of beta blockers in COPD

S Suissa, P Ernst

PMID: 18984819

Comment

Biases in the observational study of beta blockers in COPD

S Suissa et al. Thorax. 2008 Nov.

. 2008 Nov;63(11):1026-7; author reply 1027.

Authors

S Suissa, P Ernst

PMID: 18984819

No abstract available

PubMed Disclaimer

Comment on

Use of beta blockers and the risk of death in hospitalised patients with acute exacerbations of COPD.
Dransfield MT, Rowe SM, Johnson JE, Bailey WC, Gerald LB. Dransfield MT, et al. Thorax. 2008 Apr;63(4):301-5. doi: 10.1136/thx.2007.081893. Epub 2007 Oct 19. Thorax. 2008. PMID: 17951276

Similar articles

Use of beta-blockers in patients with COPD.
Andrus MR, Holloway KP, Clark DB. Andrus MR, et al. Ann Pharmacother. 2004 Jan;38(1):142-5. doi: 10.1345/aph.1D113. Ann Pharmacother. 2004. PMID: 14742808 Review.
[Usage of beta-adrenolytic agents in patients with chronic pulmonary obstructive disease].
Bułdak Ł, Duława A, Krysiak R, Okopień B. Bułdak Ł, et al. Pol Merkur Lekarski. 2008 Feb;24(140):121-4. Pol Merkur Lekarski. 2008. PMID: 18637263 Review. Polish.
Use of beta blockers in patients with COPD.
Au DH. Au DH. Thorax. 2008 Apr;63(4):296-8. doi: 10.1136/thx.2007.091280. Thorax. 2008. PMID: 18364440 No abstract available.
Is the coprescription of beta blockers and beta2 agonists justified in COPD?
Singh A. Singh A. Thorax. 2008 Nov;63(11):1026; author reply 1026. Thorax. 2008. PMID: 18984821 No abstract available.
Treatment with beta blockers in people with COPD.
Kazani S, Israel E. Kazani S, et al. BMJ. 2011 May 10;342:d2655. doi: 10.1136/bmj.d2655. BMJ. 2011. PMID: 21558358 No abstract available.

See all similar articles

Cited by

Cardiovascular disease and COPD: dangerous liaisons?
Rabe KF, Hurst JR, Suissa S. Rabe KF, et al. Eur Respir Rev. 2018 Oct 3;27(149):180057. doi: 10.1183/16000617.0057-2018. Print 2018 Sep 30. Eur Respir Rev. 2018. PMID: 30282634 Free PMC article. Review.
β-Adrenoceptor modulation in chronic obstructive pulmonary disease: present and future perspectives.
Matera MG, Calzetta L, Cazzola M. Matera MG, et al. Drugs. 2013 Oct;73(15):1653-63. doi: 10.1007/s40265-013-0120-5. Drugs. 2013. PMID: 24127222 Review.
Association between β-blocker therapy and outcomes in patients hospitalised with acute exacerbations of chronic obstructive lung disease with underlying ischaemic heart disease, heart failure or hypertension.
Stefan MS, Rothberg MB, Priya A, Pekow PS, Au DH, Lindenauer PK. Stefan MS, et al. Thorax. 2012 Nov;67(11):977-84. doi: 10.1136/thoraxjnl-2012-201945. Epub 2012 Aug 31. Thorax. 2012. PMID: 22941975 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- HighWire
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information